Optune® Approved for GBM Treatment in Canada

For the first time in 12 years, glioblastoma patients in Canada have a new treatment option.

“Optune is a medical device that works by creating Tumor Treating Fields (TTFields), which are electric fields that disrupt cancer cell division. Optune delivers TTFields therapy to the region of the tumor. Optune is small and light, weighing 2.7 pounds. This makes Optune wearable and portable, so continuous treatment can be received almost anywhere. Globally, more than 25,000 patients have been treated with Optune, to date.”

Read more from Novocure here.